Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
266,434,249
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
111,562,858
-
Shares change
-
+1,874,212
-
Total reported value, excl. options
-
$1,727,117,718
-
Value change
-
+$20,231,159
-
Put/Call ratio
-
133%
-
Number of buys
-
64
-
Number of sells
-
-22
-
Price
-
$15.48
Significant Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) as of Q4 2021
116 filings reported holding SANA - Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111,562,858 shares
of 266,434,249 outstanding shares and own 41.87% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (34,239,018 shares), BAILLIE GIFFORD & CO (11,262,030 shares), CANADA PENSION PLAN INVESTMENT BOARD (10,175,000 shares), FMR LLC (8,627,840 shares), VANGUARD GROUP INC (7,708,151 shares), BlackRock Inc. (5,970,703 shares), Public Sector Pension Investment Board (4,131,249 shares), STATE STREET CORP (3,536,339 shares), Crestline Management, LP (3,210,937 shares), and Alphabet Inc. (2,812,500 shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.